Two‐hundred and ten surgical NSCLC patients were consecutively enrolled in this study, whose RGS1 in peripheral blood mononuclear cells was determined before treatment via reverse transcriptional‐quantitative polymerase chain reaction. The gene discussed is RGS1; the disease is non-small cell lung carcinoma.